Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Global Ventricular Arrhythmia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 07:52pm CET

Research and Markets has announced the addition of the "Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Ventricular Arrhythmia Report is to understand the market and pipeline status of the drugs around the Ventricular Arrhythmia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Ventricular Arrhythmia Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ventricular Arrhythmia.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Ventricular Arrhythmia

7. Phase III Drugs for Ventricular Arrhythmia

8. Discontinued Drugs for Ventricular Arrhythmia

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cs9gkq/ventricular


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
12:36a FAMILY MEMORIALS : Announces Going Private Transaction
12:35a ITAÚ INVESTIMENTOS ITAÚ : Announcement to the Market - Sale of Material Equity Holding
12:34a Hamburger chain Wendy's to reduce antibiotic use in beef supply
12:30a SILVERCORP METALS : Provides Share Repurchase Program Update
12:30a WOW UNLIMITED MEDIA : Closes Private Placement of Convertible Debentures
12:30a SIMMONS FIRST NATIONAL : Announces Fourth Quarter Earnings Release Date and Conference Call - December 15, 2017
12:25a CENTRAIS ELETRICAS BRASILEIRAS : Market Announcement - 12.15.2017 - S&P Rating
12:25a SkyPan Calls for Recreational Drone Operators to Register with FAA
12:25a TownePlace Suites Tacoma Lakewood, Washington Opens
12:23a LOGIQ ASSET MANAGEMENT INC. : Announces Closing of Sale of Assets to Purpose Investments Inc. for Proceeds of $32 Million and Amendments to Indenture Governing LOGiQ's 7.00% Senior Unsecured Convertible Debentures
Latest news "Companies"
Advertisement